Prostate cancer is the leading cancer type in men. Getting screened can help you catch cancer early, when it’s easier to ...

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

For the third year in a row, Carver Bank, the largest Black-owned financial institution, brought prostate cancer screenings.

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Eddie Jordan has opened up about his personal health struggles in the wake of his treatment for cancer. The Formula 1 legend ...

The addition of 177Lu-PSMA-617 to enzalutamide significantly improved overall survival and QOL in patients with metastatic ...

Ghana lost 17,944 persons to cancer in 2022, recording an estimated 27, 385 new cancer cases in that year, the Ghana Health Service (GHS) has said. Professor Samuel Kaba Akoriyea, the Acting ...

With delays in biomarker testing and treatment for metastatic castration-resistant prostate cancer, continued education is ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.